IL1B and necrotizing enterocolitis: In line with these reports, our data revealed that administration of MCC950 dramatically reduced NLRP3, IL-1β, IL-6, and TNF-α expression in the brain of NEC mice, accompanied by the decrease of activated microglia and astrocytes, thus resulting in profound improvement of acute brain damage in NEC.